Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Springer Nature AG & Co KgaA (SPGG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
19.400 +0.200    +1.04%
16:38:59 - Closed. Currency in EUR
Type:  Equity
Market:  Germany
ISIN:  DE000SPG1003 
WKN:  SPG100
  • Volume: 16,241
  • Bid/Ask: 19.400 / 19.600
  • Day's Range: 19.060 - 19.620
Springer Nature 19.400 +0.200 +1.04%

Springer Nature AG & Co KgaA Company Profile

 
Get an in-depth profile of Springer Nature AG & Co KgaA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryMedia & Publishing
SectorConsumer Cyclicals
Employees

9146

Equity Type

ORD

Springer Nature AG & Co. KGaA operates as a research, health, educational, and professional publisher worldwide. It publishes science, technical, and medical content through journals under the Nature and Springer brand to research and academic research libraries, libraries of research-intensive institutions, libraries at government agencies, and corporate libraries; books in prints in various types, including monographs, textbooks, proceeding, handbook series, reference works, briefs, and others; and eBook formats, as well as offers books online under the Springer and Palgrave Macmillan brand for authors. The company offers research solutions, consisting of research authors and services, scientific discovery and expert database offerings and services, and other solutions for organizations. In addition, it is involved in the publication and scientific communication services, and medical education and pharma sales force training materials; journal reprints and e-prints; customized published content and image collection; content and services for drug treatment education and devices and diagnostics; specialist information and services; publication, learning solutions, and services; and the provision of multi-specialty, online-only journal for the healthcare sector. Further, the company provides English language teaching and K12 curriculum; and engineering and management that focuses on publications, online information tools, and events for professionals in the areas of automotive, engineering, management, and materials sectors. The company was founded in 1842 and is headquartered in Berlin, Germany. Springer Nature AG & Co. KGaA is a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH.

Contact Information

Address Heidelberger Platz 3
Berlin, 14197
Germany
Phone 49 30 827 870
Fax -

Top Executives

Name Age Since Title
Obi Bettina Felten 52 2018 Member of Supervisory Board
Bjorn Waldow 50 2022 Member of Supervisory Board
Ewald Walgenbach 65 2018 Member of Supervisory Board
Sabine Knauer 51 2024 Member of Supervisory Board
Nikolaos Stathopoulos 55 2019 Deputy Chair of Supervisory Board
Birgit Haderer 46 2020 Member of Supervisory Board
Stefan Oschmann 68 2018 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SPGG Comments

Write your thoughts about Springer Nature AG & Co KgaA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email